The Metabolic Classroom with Dr. Ben Bikman

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Dr. Ben Bikman explains why constant hunger is often driven by hormones rather than a lack of willpower. He begins by showing how meals high in rapidly digested carbohydrates can trigger large insulin spikes, causing fuel to move quickly out of the bloodstream and into storage. Even though the body has plenty of stored energy, the brain senses that available fuel has dropped and responds by making you feel hungry again.

Ben then explores three key hormones that regulate fullness: GLP-1, leptin, and insulin. Some people produce less GLP-1 after carbohydrate-rich meals, while others become resistant to leptin and insulin in the brain, weakening the signals that normally reduce appetite and cravings.

The takeaway is that persistent hunger is often a signaling problem rather than simply a discipline problem. By lowering chronic insulin levels and improving insulin sensitivity, the body's natural hunger and fullness signals can begin working the way they were designed to.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

In this lecture, Dr. Ben Bikman explains why visceral fat is one of the most metabolically dangerous forms of body fat. Unlike subcutaneous fat, which sits under the skin and can be pinched, visceral fat is stored deep inside the abdomen around the organs. Its location matters because visceral fat drains directly into the liver through the portal vein, meaning the fatty acids and inflammatory signals it releases reach the liver first and at high concentration.

Dr. Bikman explains that visceral fat is especially harmful because it tends to grow through hypertrophy, meaning existing fat cells get larger rather than new smaller fat cells being created. As these fat cells enlarge, they become insulin resistant and begin leaking fatty acids even when insulin should be suppressing fat release. Those fatty acids can then accumulate in the liver, pancreas, and muscle, contributing to ectopic fat storage, fatty liver disease, and worsening insulin resistance.

The lecture also highlights how enlarged visceral fat cells can become hypoxic, or oxygen-starved, which pushes them to release inflammatory signals and recruit immune cells. This turns visceral fat into an active source of chronic low-grade inflammation. The hopeful takeaway is that visceral fat is also highly responsive to catecholamines, the hormones released during physical activity. Exercise can therefore help reduce visceral fat specifically, even when overall body weight does not change dramatically.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

#VisceralFat #InsulinResistance #FattyLiver #MetabolicHealth #BellyFat #Inflammation #EctopicFat #PortalVein #ExerciseScience #Catecholamines #SubcutaneousFat #FatCells #Hypoxia #MetabolicDisease #LowCarbScience #DrBenBikman #MetabolicClassroom #MetabolismMatters #HealthScience #FatLoss
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Bone is a metabolically active organ that responds to insulin and glucose while releasing hormones that influence the pancreas, fat cells, appetite, and energy use. High glucose and insulin resistance can make bones brittle despite normal density, while resistance training, stable glucose, and good nutrition support both skeletal and metabolic health.

Summary:
Dr. Bikman explains why bone should be understood as a metabolic organ, not just structural scaffolding. Bone is living tissue that is constantly being broken down and rebuilt by opposing teams of cells, and that remodeling process requires energy, nutrients, and hormonal coordination. Far from being inert, bone responds to metabolic signals such as insulin, glucose, and leptin—and it sends signals back to the rest of the body.

Ben focuses first on insulin’s role in bone health. Insulin acts as a growth signal for bone-building cells, helping maintain bone density and structure. In type 1 diabetes, where insulin is absent, bone density and architecture suffer. In type 2 diabetes, the problem is different: bone density may look normal on a DEXA scan, but chronically high glucose can glycate collagen, making bone stiffer and more brittle. At the same time, insulin resistance weakens the bone-building signal, creating the “diabetic bone paradox,” where bones appear dense but fracture more easily.

The lecture then explores bone-derived hormones, especially osteocalcin and lipocalin-2. Osteocalcin can support insulin secretion under glucose stimulation, increase adiponectin from fat cells, improve insulin sensitivity, reduce inflammation, and promote fat burning. Lipocalin-2 travels from bone to the brain after meals and appears to help suppress appetite while also supporting glucose regulation. The practical takeaway is that metabolic health and bone health are deeply connected: stable glucose, good insulin sensitivity, vitamin K, resistance training, and weight-bearing movement all help protect the skeleton and support whole-body metabolism.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

In this Metabolic Classroom episode, Dr. Bikman explains mitochondrial uncoupling, a process where cells burn fuel without converting all of that energy into usable ATP. Normally, mitochondria are “coupled,” meaning fuel burning is efficiently converted into cellular energy. But when mitochondria become uncoupled, some of that fuel is released as heat instead—like revving a car engine while it’s in park.

Ben explains that this process is especially important in fat tissue. White fat is designed for energy storage and tends to be tightly coupled, while brown fat is rich in mitochondria and uncoupling proteins that burn fuel to generate heat. He then connects this physiology to insulin, showing that insulin appears to make fat-cell mitochondria more tightly coupled and efficient, lowering energy expenditure and making storage easier.

The opposite happens when insulin is low and ketones rise. Research from Dr. Bikman’s lab shows that ketones, especially beta-hydroxybutyrate, can increase mitochondrial respiration in fat cells without a matching rise in ATP production—clear evidence of uncoupling. In human fat biopsies, elevated ketones were associated with markedly higher mitochondrial respiration, suggesting that ketosis can make fat tissue more wasteful with energy.

The larger takeaway is that calories still matter, but hormones influence how efficiently those calories are stored or burned. When insulin is high, the body stores energy efficiently. When insulin is low and ketones are elevated, fat-cell mitochondria may become more uncoupled, allowing more energy to be dissipated as heat rather than stored as fat.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Amylin is an insulin-sparing satiety hormone released with insulin that slows digestion, restrains glucagon, and helps reduce post-meal glucose spikes. New amylin-based therapies, especially when combined with GLP-1 drugs, may offer powerful weight-loss effects by restoring natural fullness signals rather than forcing insulin higher.

Summary:
In this lecture, Dr. Bikman explains amylin, a hormone released from the pancreatic beta cell alongside insulin. While insulin helps move nutrients into tissues, amylin works mainly through the brain and digestive tract to increase fullness, slow gastric emptying, restrain post-meal glucagon, and reduce blood sugar spikes without forcing insulin higher. This makes amylin an insulin-sparing hormone and a natural complement to GLP-1.

Ben explains why amylin was difficult to turn into a drug: human amylin naturally tends to misfold and form amyloid deposits in the pancreas. Protein engineering solved this problem by creating analogs that activate the amylin receptor without clumping. The first amylin-based drug, pramlintide, proved the concept by reducing appetite, slowing digestion, blunting post-meal glucose rises, and producing modest weight loss, though its short duration and nausea limited broader use.

The lecture then moves into newer amylin-based therapies, especially cagrilintide and the combination drug CagriSema, which pairs cagrilintide with semaglutide. Because amylin and GLP-1 work through overlapping but distinct brain pathways, the combination produces greater weight loss than either hormone strategy alone. The takeaway is that amylin may become one of the most important next-generation targets in metabolic medicine because it supports satiety and glucose control without driving insulin higher.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.
Hosted on Acast. See acast.com/privacy for more information.